Global Pharma Handbook 2022: Your Regulatory Guide to the Global Pharma Industry –

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Handbook 2022” directory was added to from offer.

Your regulatory guide to the pharmaceutical industry worldwide!

The completely revised and expanded Global Pharma Handbook provides pharmaceutical industry decision makers with a single source of accurate, up-to-date information and analysis on prescription drug companies and regulatory environments around the world. Coverage of over 70 individual countries (cumulatively representing over 97% of global sales) and an EU summary section are included.

Business executives, consultants, marketing and licensing partners, policy makers, researchers, investors, journalists and others working with the pharmaceutical industry will benefit from the Global Pharma Handbook.

Whether you’re working on a cutting-edge specialty drug or a mature generic, whether your drug is on the market or still in clinical trials, the Global Pharma Handbook is a comprehensive, data-rich report that gives you insight into structures, trends and regulations that govern eight of the world’s largest pharmaceutical markets.

Market Coverage (including updated contact details for all countries):

European Union: All 28 countries

Europe (outside EU): Norway Russia, Switzerland, Ukraine

Asia Pacific: Australia, China, India, Indonesia, Japan, Korea, Malaysia, New Zealand, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam

Latin America: Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, Peru

Middle East: Bahrain, Egypt, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, Turkey, United Arab Emirates

Africa: Kenya, Nigeria, Tanzania, South Africa, Uganda

North America: Canada, United States

Information for 70 countries on:

  • Approval procedures

  • Branded use vs generic use

  • Clinical Trials Regulations and Practices

  • Distribution systems

  • Drug Regulatory Agencies and Policies

  • Generic regulations and market trends

  • Growth rates

  • Health systems

  • Intellectual property and parallel trade issues

  • Intellectual property regulations and practices

  • Manufacturing infrastructure

  • Marketing regulations and practices

  • Payment models

  • Pharmaceutical Market Forecast

  • Structure of the pharmaceutical market

  • Characteristics of the population and prescribers

  • Price regulation

  • Public and private payment and reimbursement systems

  • R&D incentives

  • Regulatory bodies

  • Research, distribution and marketing

  • Sales & Consumption

  • Sales channels

  • Trade policies

For more information on this directory, visit

Calvin W. Soper